Cargando…

Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study

INTRODUCTION: The clinical course of high-grade cervical intraepithelial neoplasia (CIN2/3) is characterised by a high spontaneous regression rate. Histological assessment is unable to differentiate between CIN2/3 lesions likely to regress and those likely to persist or progress. Most CIN2/3 lesions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kremer, Wieke W, Berkhof, Johannes, Bleeker, Maaike CG, Heideman, Daniëlle AM, van Trommel, Nienke E, van Baal, Marchien W, Verhoeve, Harold R, Meijer, Chris JLM, Kenter, Gemma G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Obstetrics and Gynaecology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629415/ https://www.ncbi.nlm.nih.gov/pubmed/31289088 http://dx.doi.org/10.1136/bmjopen-2019-029017

Ejemplares similares

Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study)
por: Kremer, Wieke W., et al.
Publicado: (2022)

Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection
por: van den Helder, Rianne, et al.
Publicado: (2020)

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
por: Vink, Frederique J., et al.
Publicado: (2019)

Three-tiered score for Ki-67 and p16(ink4a) improves accuracy and reproducibility of grading CIN lesions
por: van Zummeren, Marjolein, et al.
Publicado: (2018)

Performance of HPV E4 and p16(INK4a) biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study
por: Damgaard, Rikke Kamp, et al.
Publicado: (2022)

Classification of high‐grade cervical intraepithelial neoplasia by p16(ink4a), Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management
por: Vink, Frederique J., et al.
Publicado: (2021)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test
por: Polman, Nicole J, et al.
Publicado: (2017)

CIN III lesions and regression: retrospective analysis of 635 cases
por: Motamedi, Melodi, et al.
Publicado: (2015)

Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
por: Bonde, Jesper, et al.
Publicado: (2020)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years
por: Vink, Frederique J, et al.
Publicado: (2022)

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival
por: Halle, Mari K., et al.
Publicado: (2021)

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
por: De Strooper, Lise M.A., et al.
Publicado: (2016)

Intra‐ and inter‐laboratory agreement of the FAM19A4/mir124‐2 methylation test: Results from an international study
por: Floore, Arno, et al.
Publicado: (2019)

HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions
por: Bleeker, M C G, et al.
Publicado: (2005)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

Mesenchymal Stem Cells from Cervix and Age: New Insights into CIN Regression Rate
por: Orciani, Monia, et al.
Publicado: (2018)

HPV16 variant analysis in primary and recurrent CIN2/3 lesions demonstrates presence of the same consensus variant
por: van der Weele, Pascal, et al.
Publicado: (2019)

Genome‐wide microRNA analysis of HPV‐positive self‐samples yields novel triage markers for early detection of cervical cancer
por: Snoek, Barbara C., et al.
Publicado: (2018)

Experiences and preferences towards collecting a urine and cervicovaginal self-sample among women attending a colposcopy clinic
por: Schaafsma, Mirte, et al.
Publicado: (2022)

HPV infection and number of lifetime sexual partners are strong predictors for ‘natural’ regression of CIN 2 and 3
por: Chan, J K, et al.
Publicado: (2003)

Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease
por: Babion, Iris, et al.
Publicado: (2019)

The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review
por: Kremer, WW, et al.
Publicado: (2020)

Different methods of pain relief for IVF and ICSI oocyte retrieval – A Dutch survey
por: Roest, Inez, et al.
Publicado: (2019)

Operative hysteroscopy versus ultrasound-guided electric vacuum aspiration for removal of retained products of conception: A prospective cohort study()
por: Wagenaar, Liselot P., et al.
Publicado: (2023)

Somatic mutation in PIK3CA is a late event in cervical carcinogenesis
por: Verlaat, Wina, et al.
Publicado: (2015)

Detection of hypermethylated genes as markers for cervical screening in women living with HIV
por: Kremer, Wieke W, et al.
Publicado: (2018)

Evaluation of CIN2/3 Lesion Regression in GynTect(®) DNA Methylation-Marker-Negative Patients in a Longitudinal Study
por: Hoyer, Heike, et al.
Publicado: (2023)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
por: Bulk, S, et al.
Publicado: (2007)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

Cervical cancer detection by DNA methylation analysis in urine
por: Snoek, Barbara C., et al.
Publicado: (2019)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
por: Rotman, Jossie, et al.
Publicado: (2020)

The use of molecular markers for cervical screening of women living with HIV in South Africa
por: Kremer, Wieke W., et al.
Publicado: (2019)

A rare cause of pneumoperitoneum
por: Selvakumari, NK, et al.
Publicado: (2011)

An unusual case of small bowel obstruction post caesarean section
por: Marchocki, Z, et al.
Publicado: (2011)

Endometrial appearance in the presence of communicating hydrosalpinx
por: Heitmann, RJ, et al.
Publicado: (2012)

Polymicrobial abdominal wall necrotizing fasciitis after cesarean section
por: DeMuro, JP, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i1u59lahhbjfg4qj0d7inp07ka